Inner Banner

2023

breadCrumb

Submitted by admin on Fri, 02/23/2024 - 15:00
Type
common
  1. Acharekar A, Bachal K, Shirke P, Thorat R, Banerjee A, Gardi N, Majumder A, Dutt S (2023). Substrate stiffness regulates the recurrent glioblastoma cell morphology and aggressiveness. Matrix Biology. 115: 107-127. PMID: 36563706

  2. Ambulkar R, Parab S, Vignesh B, Nagargoje V, Janu A, Parikh P, Moiyadi A. (2023) A prospective study to evaluate the use of surveillance venous ultrasonography to detect incidence of deep venous thrombosis following neurosurgical excision of brain tumors. Journal of Neurosciences in Rural Practice.14(2):252-257. PMID: 37181162

  3. Anjikar A, Jadhav P, Hole A, Panneerselvam R, Ingle A, Yamamoto T, Noothalapati H, CM Krishna (2023). Removal of hemolysis interference in serum Raman spectroscopy by multivariate curve resolution analysis for accurate classification of oral cancers. Sensors and Diagnostics. 2:390-97.

  4. Anwaar A, Varma AK, Baruah R (2023). In silico-based structural evaluation to categorize the pathogenicity of mutations identified in the RAD class of proteins. ACS Omega. 8(11):10266-10277.PMID: 36969410

  5. Arun B, Joshi M, Kakkar AK, Madki S, Ivaturi V, Chinnaswamy G, Banavali S, Gota V (2023). Bioequivalence study followed by model-informed dose optimization of a powder for oral suspension of 6-mercaptopurine. Pediatric Blood & Cancer.PMID: 38110844

  6. Asija S, Chatterjee A, Goda JS, Yadav S, Chekuri G, Purwar R. (2023). Oncolytic immunovirotherapy for high-grade gliomas: A novel and an evolving therapeutic option. Frontiers in Immunology. PMID: 37006286

  7. Bagal S, Budukh A, Singh Thakur J, Dora T, Qayyumi B, Khanna D, Fernandes D, Chakravarti P, Singh R, Patil S, Dikshit R, Chaturvedi P. Head and neck cancer burden in India: an analysis from published data of 37 population-based cancer registries. Ecancer.17:1603. PMID: 37799939

  8. Bagal B, Sarma R, Dey S, Nayak L, Bonda A, Goda J, Khanna N, Dasgupta A, Kakoti S, Chatarjee A, Jain H, Epari S, Laskar S, Sengar M, Gupta T (2023). Lenalidomide following whole-brain radiotherapy in patients with primary central nervous system lymphoma ineligible for intensive systemic therapy. British Journal of Haematology. 201(1):150-153. PMID: 36682363.

  9. Biswas D, Halder A, Barpanda A, Ghosh S, Chauhan A, Bhat L, Epari S, Shetty P, Moiyadi A, Ball GR, Srivastava S (2023). Integrated Meta-Omics Analysis Unveils the Pathways Modulating Tumorigenesis and Proliferation in High-Grade Meningioma. Cells. 12(20):2483.PMID: 37887327

  10. Ballinger ML, Pattnaik S, Mundra PA.... Puri A, Sarin R (2023). et al. Heritable defects in telomere and mitotic function selectively predispose to sarcomas. Science. 379(6629):253-260. PMID: 36656928.

  11. Banerjee A, Halder A, Jadhav P, Sarkar A, Hole A, Shastri J, Agrawal S, CM Krishna, Srivastava S (2023). SARS-CoV-2 severity classification from plasma sample using Confocal Raman spectroscopy. Journal of Raman Spectroscopy. 54(1): 124-132

  12. Barrios C, de Lima Lopes G, Yusof MM, Rubagumya F, Rutkowski P, Sengar M (2023). Barriers in access to oncology drugs - a global crisis. Nature Reviews Clinical Oncology. 20(1):7-15. PMID: 36380066

  13. Baviskar Y, Likonda B, Pant S, Mokal S, Pawar A, Dasgupta A, Chatterjee A, Gupta T. Short-course palliative hypofractionated radiotherapy in patients with poor-prognosis high-grade glioma: Survival and quality of life outcomes from a prospective phase II study. Clinical Oncology.35 (10):e573-e581. PMID: 37455146

  14. Bhatla N, Muwonge R, Malvi SG, Joshi S, Poli URR, Lucas E, Esmy PO, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Vashist S, Mishra G, Jadhav R, Siddiqi M, Anantharaman D, Panicker G, Butt J, Sankaran S, Kannan TPRA, Varghese R, Kartha P, Pillai MR, Waterboer T, Müller M, Sehr P, Unger ER, Sankaranarayanan R, Basu P. Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine. Human Vaccines Immunotherapeutics. 19(3):2289242. PMID: 38078840.

  15. Bindal A, Mittal P, Shinghal A, Scaria L, Prajapati K, Swamidas J, Gurram L, Berger D, Sturdza A, Chopra S (2023). Sigmoid dose accumulation and reporting for multifractionated brachytherapy for cervical cancer: Methodological development of sigmoid points through virtual endoscopic method. Brachytherapy. 22(3):325-333. PMID: 36882345

  16. Biswas S, Anadon CM, Conejo-Garcia JR (2023). Antibodies target intracellular oncodrivers through PIGR-mediated transcytosis. Genes & Immunity.PMID: 38092884.

  17. Biswas S, Mandal G, Anadon C, Chaurio R, Lopez-Bailon L, Nagy M, Mine J, Hänggi K, Sprenger K, Innamarato P, Harro C, Powers J, Johnson J, Fang B, Eysha M, Nan X, Li R, Perez B, Curiel T, Yu X, Rodriguez P, Conejo-Garcia J (2023). Targeting intracellular oncoproteins with dimeric IgA promotes expulsion from the cytoplasm and immune-mediated control of epithelial cancers. Immunity.56(11):2570-2583.e6 PMID: 37909039

  18. Boppana M, Sengar M, Jain H, Gurjar M, Ambotkar M, Gota V, Bonda A, Bagal B, Thorat J, Gokarn A, Nayak L, Shetty N, Baheti A, Mokal S, Kannan S, Shetty A, Eipe T (2023). A prospective study to evaluate the effect of therapeutic drug monitoring-based posaconazole prophylaxis on invasive fungal infection rate during acute myeloid leukemia induction therapy. Indian Journal of Hematology and Blood Transfusion

  19. Budrukkar A, Murthy V, Kashid S, Swain M, Rangarajan V, Ghosh-Laskar S, Kannan S, Kale S, Upreti R, Pai P, Pantvaidya G, Gupta T, Agarwal JP (2023). Intensity Modulated Radiation Therapy Alone Vs Intensity modulated radiation therapy and brachytherapy for T1-T2N0M0 oropharyngeal cancers: Results from A randomized controlled trial. International Journal of Radiation Oncology, Biology, Physics. S0360-3016(23)07854-9. PMID: 37660737

  20. Budukh A, Kadam P, Singh D, Thakur JS (2023). Innovative field methods for residence confirmation and updating follow-up status of cancer cases: Experience from rural cancer registry, Punjab, India. Clinical Epidemiology and Global Helath. 22: 101329.

  21. Butti R, Kapse P, Bhadauriya G, Ahmad S, Chaubal R, Parab P, Kadam R, Mahapatra SS, Shet T, Dutt A, Gupta S, Kundu GC(2023). Development and characterization of a patient derived orthotopic xenograft of therapy resistant breast cancer. Oncology Reports. 49(5): 99. PMID: 36999625

  22. Chakraborty N, Jain BK, Shembekar S, Bhattacharyya D (2023). ER exit sites (ERES) and ER-mitochondria encounter structures (ERMES) often localize proximally. FEBS Letters. 597(2):320-336. PMID: 36103135

  23. Chakraborty S, Baruah R, Mishra N, Varma AK (2023). In-silico and structure-based assessment to evaluate pathogenicity of missense mutations associated with non-small cell lung cancer identified in the Eph-ephrin class of proteins. Genomics and Informatics.21(3):e30.PMID: 37813626

  24. Chakraborty S, Shenoy PS, Mehrotra M, Phadte P, Singh P, Rekhi B, Ray P. Through the looking Glass: Updated insights on ovarian cancer diagnostics. Diagnostics. 13(4): 713. PMID: 36832201

  25. Chakravorty G, Ahmad S, Godbole MS, Gupta S, Badwe RA, Dutt A (2023). Deciphering the mechanisms of action of progesterone in breast cancer. Oncotarget. 14: 660-667.PMID: 37395734

  26. Chatterjee G, Patkar N (2023). United we stand, divided we fall. Multicentre standardization of measurable residual disease assessment in acute leukaemia is the way forward. British Journal of Haematology. 200(3):277-279 PMID: 36282207

  27. Chaubal K, Shetty D, Mohanty P, Walunj K, Tembhare P, Patkar N, Narula G (2023). B-cell acute lymphoblastic leukemia with t(5;9)(q22;q34.1) involving the SNX2 and ABL1. Atlas of Genetics and Cytogenetics in Oncology and Haematology.

  28. Chavan A, Shriyan B, Chavan P, Shirsat A, Gavhane U, Pillai B, Bhat V, Dhamne C, Gota V (2023). Covid antibody titers in cancer patients following vaccination with ChAdOx1 nCOV-19 vaccine. South Asian Journal of Cancer.

  29. Chavan P, Dey R, Castelino R, Kamble A, Poladia P, Bagal R, Jadhav M, Shirsat A, Chavan A, Dhumal S, Kumar S, Krishnamurty MN, Bhat V, Bhattacharjee A, Gota V (2023). Safety, immunogenecity and effectiveness of ChAdOx1 nCoV-19 vaccine during the second wave of pandemic in India: a real-world study. Drug Metabolism and Personalized Therapy. 38(3):227-236. PMID: 37098129.

  30. Chen Y, Li H, Janowczyk A, Toro P, Corredor G, Whitney J, Lu C, Koyuncu CF, Mokhtari M, Buzzy C, Ganesan S, Feldman MD, Fu P, Corbin H, Harbhajanka A, Gilmore H, Goldstein LJ, Davidson NE, Desai S, Parmar V, Madabhushi A (2023). Computational pathology improves risk stratification of a multi-gene assay for early stage ER+ breast cancer. NPJ Breast Cancer. 9(1):40. PMID: 37198173

  31. Chikhale V, Goswami N, Khan MA, Borah P, Varma AK (2023). Evaluation of pathogenicity and structural alterations for the mutations identified in the conserved region of the C‑terminal kinase domain of Human-Ribosomal S6 Kinase 1. ACS Omega. 8(18):16273-16283. PMID: 37179615

  32. Chilukuri S, Mallick I, Agrawal A, Maitre P, Arunsingh M, James FV, Kataria T, Narang K, Gurram BC, Anand AK, Utreja N, Dutta D, Pavamani S, Mitra S, Mallik S, Mahale N, Chandra M, Chinnachamy AN, Shahid T, Raghunathan MS, Kannan V, Mohanty SK, Basu T, Hotwani C, Panigrahi G, Murthy V (2023). Multi-institutional clinical outcomes of biopsy gleason grade group 5 prostate cancers treated with contemporary high-dose radiation and long-term androgen deprivation therapy. Clinical oncology. 35(7):454-462. PMID: 37061457

  33. Chopra S, Gupta A, Aoyama H, Wu HG, Mahmood H, Tharavichitkul E, Khine A, Gandhi A, Faruque GM, Cruz M, Kodrat H, Xue X, Abeysinghe P, Ho GF, Minjgee M, Tey J, Gao X (2023). Radiation Oncology Research in Asia: Current Status and a Peep into the future from the federation of Asian Organizations for Radiation Oncology. JCO Global Oncology.PMID: 37384859

  34. Chopra S, Mulani J, Mittal P, Singh M, Shinde A, Gurram L, Scaria L, Dheera A, Kolhe S, Rane P, Ghadi Y, Rath S, Ghosh J, Gulia S, Gupta S, Kinhikar R, Laskar S, Agarwal J (2023). Early outcomes of abbreviated multi-fractionated brachytherapy schedule for cervix cancer during COVID-19 pandemic. Brachytherapy. 22(2): 125–131.PMID: 36585283

  35. Choudhary B, Chaudhary N, Shah M, Dwivedi N, Smitha PK, Das M, Dalal SN (2023). Lipocalin 2 inhibits actin glutathionylation to promote invasion and migration. FEBS Letters.597(8):1086-1097 PMID: 36650979

  36. Chougule A, Chandrani P, Noronha V, Pange P, Kale S, Nikam A, Nambiar K, Marchande D, Durve A, Gupta V, Jagtap V, Tiwrekar P, Menon N, Joshi A, Kaushal R, Pai T, Patil V, Dutt A, Banavali S, Prabhash K (2023). Real world evidence of EGFR targeted therapy in non-small cell lung cancer– a brief report of decade long single centre experience. JTO Clinical and Research Reports.

  37. Christie J, Anthony CM, Harish M, Mudartha D, Farooqee SBUD, Venkatraman P (2023). The interaction network of the proteasome assembly chaperone PSMD9 regulates proteostasis. FEBS Journal. 290(23):5581-5604. PMID: 37665644.

  38. Das CG, Kumar VG, Kode J (2023).Green nanotechnology approaches using Mesobacillus jeotgali ADCG SIST 4 strain synthesized gold nanoparticles for anticancer studies. Journal of Drug Delivery Science and Technology.

  39. Das L, Shekhar S, Chandrani P, Varma AK.(2023) In silico structural analysis of secretory clusterin to assess pathogenicity of mutations identified in the evolutionarily conserved regions.Journal of Biomolecular Structure & Dynamics.41(2):469-478. PMID: 34821197.

  40. Das S, Sakhare N, Kumar D, Mathur A, Mirapurkar S, Sheela M, Mohanty B, Chaudhari P, Chakraborty S. Design, characterization and evaluation of a new 99mTc-labeled folate derivative with affinity towards folate receptor. Bioorganic Medicinal Chemistry Letters. 86:129240. PMID: 36931350.

  41. Dubey S, Mishra N, Shelke R, Varma AK (2023). Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. FEBS Journal. PMID: 38129745.

  42. Dwivedi P, Sawant V, Vajarkar V, Vatsa R, Choudhury S, Jha AK, Rangarajan V (2023). Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector. Nuclear Medicine Communications. 44(1):56-64. PMID: 36449665.

  43. Datta D, Dasgupta A, Chatterjee A, Sahu A, Bhattacharyya K, Meena L, Joshi K, Puranik A, Dev I, Moiyadi A, Shetty P, Singh V, Patil V, Menon N, Epari S, Sahay A, Gupta T (2023). Imaging-based patterns of failure following re-irradiation for recurrent/progressive high-grade glioma †. Journal of Personalized Medicine. 13(4): 685.PMID: 37109071

  44. Dey P, Gadewal N, De A (2023). Pathogenic HER3 dimerization domain mutations create a structural bias towards un-conventional EGFR-HER3 signalling axis in breast cancer. International Journal of Biological Macromolecules. 242(Pt 2):124765. PMID: 37156315

  45. Dharavath B, Butle A, Pal A, Desai S, Upadhyay P, Rane A, Khandelwal R, Manavalan S, Thorat R, Sonawane K, Vaish R, Gera P, Bal M, D'Cruz AK, Nair S, Dutt A (2023). Role of miR-944/MMP10/AXL- axis in lymph node metastasis in tongue cancer. Communications Biology. 6(1):57. PMID: 36650344

  46. Dhumal S, Patil V, Parekh D, Noronha V, Menon N, Peelay Z, Nawale K, Prabhash K (2023). Long term outcomes of phase I/II study of palliative triple metronomic chemotherapy in platinum-refractory/early failure oral cancer. Lancet Regional Health - Southeast Asia. 12:100143. PMID: 37384062

  47. Dilli Batcha JS, Raju AP, Matcha S, Raj SEA, Udupa KS, Gota, V, Mallayasamy S (2023). Factors influencing pharmacokinetics of tamoxifen in breast cancer patients: A systematic review of population pharmacokinetic models. Biology. 12:51. PMID: 36671744

  48. D'Silva SZ, Singh M, Pinto AS (2023). NK cell defects: implication in acute myeloid leukemia. Frontiers in Immunology. 14: 1112059. PMID: 37228595

  49. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). Identification of the novel allele, HLA-C*06:02:38:02, in a Gujarati individual from India. HLA. 101(1):69-70. PMID: 36087312.

  50. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). Identification of the novel HLA-DQA1*01:01:01:11 and -DQA1*01:03:01:13 alleles in individuals from India. HLA. 101(3):296-297 PMID: 36394229.

  51. D'Silva SZ, Tambe M, Pinto AS, Singh M (2023). The novel HLA-B*52:01:01:23 allele in an individual from Uttar Pradesh, North India. HLA. 101(1):56-57. PMID: 36086925.

  52. Dubey S, Mishra N, Shelke R, Varma AK (2023). Mutations at proximal cysteine residues in PML impair ATO binding by destabilizing the RBCC domain. FEBS Journal. PMID: 38129745.

  53. Dutta RP, Kumar R, Tembhare PR, Bagal B, Swain RK, Hasan SK. Targeting transcriptional kinase of CDK7 halts proliferation of multiple myeloma cells by modulating the function of canonical NF-kB pathway and cell cycle regulatory proteins. Translational Oncology. 35:101729. PMID: 37369156

  54. Dwivedi P, Sawant V, Vajarkar V, Vatsa R, Choudhury S, Jha AK, Rangarajan V. Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector. Nuclear Medicine Communications. 44(1):56-64. PMID: 36449665.

  55. Ecker S, Kirisits C, Schmid M, De Leeuw AAC, Seppenwoolde Y, Knoth J, Trnkova P, Heilemann G, Sturdza A, Kirchheiner K, Spampinato S, Serban M, Jürgenliemk-Schulz IM, Chopra S, Nout R, Tanderup K, P¨otter R, Eder-Nesvacil N (2023). Tools for large-scale data analytics of an international multi-center study in radiation oncology for cervical cancer. Radiotherapy and Oncology. 182:109524. PMID: 36764459

  56. Fields E, Chopra S, Ludwig M, Taunk N, Chino J (2023). Pivotal science from the 2022 International Gynecologic Cancer Society Meeting. International Journal of Radiation Oncology, Biology, Physics. 116(3): 473-478.

  57. Gandhi VV, Gandhi KA, Goda JS, Kumbhare LB, Gota V, Kunwar A (2023). Post-radiation treatment of 3,3'-diselenodipropionic acid augments cell kill by modulating DNA repair and cell migration pathways in A549 cells. IUBMB Life. 75(10):811-829. PMID: 37072689.

  58. Garg M, Gandhi K, Jadhav SM, Gurjar M, Gota V (2023). Effect of moderate malnutrition on the pharmacokinetics of etoposide and vincristine in freshly weaned rats. European Journal of Drug Metabolism and Pharmacokinetic 48(6):657-663.PMID: 37700116

  59. Gaur T, Poddutoori R, Khare L, Bagal B, Rashmi S, Patkar N, Tembhare P, Pg S, Shetty D, Dutt A, Zhang Q, Konopleva M, Platzbeckar U, Gupta S, Samajdar S, Ramchandra M, Khattry N, Hasan SK. Novel covalent CDK7 inhibitor potently induces apoptosis in acute myeloid leukemia and synergizes with Venetoclax. J Exp Clin Cancer Res. 42(1):186. PMID: 37507802

  60. Gawali P, Saraswat A, Bhide S, Gupta S, Patel K (2023). Human solid tumors and clinical relevance of the enhanced permeation and retention effect: a 'golden gate' for nanomedicine in preclinical studies? Nanomedicine (Lond). 18(2):169-190PMID: 37042320

  61. Ghantasala S, Bhat A, Agarwal U, Biswas D, Bhattarai P, Epari S, Moiyadi A, Srivastava S (2023). Deep Proteome investigation of high-grade gliomas reveals heterogeneity driving differential metabolism of 5-Aminolevulinic acid. Neuro-Oncology Advances. 5(1): vdad065..PMID: 37358939

  62. Ghantasala S, Bhat A, Epari S, Moiyadi A, Srivastava S (2023). High-Grade Gliomas from Subventricular Zone: Proteomic Drivers of Aggressiveness Using Fluorescence-Guided Multiple Sampling. OMICS: A Journal of Integrative Biology. 27(12):598-606 PMID: 38055199.

  63. Gholap D, Dikshit R, Chaturvedi P, Chaturvedi A, Majrekar A, Mhatre S (2023). Exclusive use of different types of tobacco products, exposure to second hand tobacco smoke and risk of subtypes of head and neck cancer among Indian males. International Journal of Cancer. 152(3): 374-383.PMID: 36054453

  64. Ghosh Laskar S, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, D'Cruz A (2023). Oral Cavity Adjuvant Therapy (OCAT) -A phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) vs concurrent CT-RT vs accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer. 181:179-187. PMID: 36669426

  65. Ghosh Laskar S, Sinha S, Gupta M, Karmakar S, Nivedha J M, Kannan S, Budrukkar A, Swain M, Kumar A, Gupta T, Murthy V, Chaukar D, Pai P, Chaturvedi P, Pantvaidya G, Nair D, Nair S, Thiagarajan S, Deshmukh A, Noronha V, Patil V, Joshi A, Prabhash K, Agarwal JP (2023). Prophylactic versus reactive feeding approach in patients undergoing adjuvant radiation therapy for oral cavity squamous cell carcinoma: A propensity score matched-pair analysis. Head Neck. 45(5):1226-1236. PMID: 36912016.

  66. Giri P, Bharti A, Kode J, Begum R, Dwivedi M. Harmine and Kaempferol treatment enhances NFATC1 and FOXP3 mediated regulatory T-cells’ suppressive capacity in generalized vitiligo. International Immunopharmacology. 125(Part B):111174.PMID: 37951194

  67. Gohil D, Panigrahi GC, Gupta SK, Gandhi KA, Gera P, Chavan P, Sharma D, Sandur S, Gota V (2023). Acute and sub-acute oral toxicity assessment of 5-hydroxy-1,4-naphthoquinone in mice. Drug and Chemical Toxicology. 46(4): 795-708.PMID: 35899689.

  68. Gokarn A, Shenoy R, Punatar S, Mirgh S, Chichra A, Nayak L, Bonda A, Jindal N, Saroha M, Toshniwal A, Prayag P, Tripathi R, Kumar S, Bhat V, Biswas S, Khattry N (2023). Efficacy of artesunate for treatment of cytomegalovirus reactivation post allogeneic haematopoietic stem cell transplants. Bone Marrow Transplantation. 58(2):209-211 PMID: 36310244.

  69. Gokarn A, Tembhare PR, Syed H, Sanyal I, Kumar R, Parab S, Khanka T, Punatar S, Kedia S, Ghogale SG, Deshpande N, Nikam Y, Girase K, Mirgh S, Jindal N, Bagal B, Chichra A, Nayak L, Bonda A, Rath S, Hiregoudar S, Poojary M, Saha S, Ojha S, Subramanian PG, Khattry N (2023). Long-term cryopreservation of peripheral blood stem cell harvest using low concentration (4.35%) dimethyl sulfoxide with methyl cellulose and uncontrolled rate freezing at -80°C: An effective option in Resource Limited Setting. Transplantation and Cellular Therapy. 29 (12): 777.e1-777.e8. PMID: 37678607

  70. Grover S, Lichter K, Likhacheva A, Jang J, Ning M, Robin T, Small W, Kudchadker R, Swamidas J, Chopra S, Rai B, Dutt Sharma S, Sharma D, Kuppusamy T, Yang R, Berger D, Mendez L, Glaser S, Erickson D, Chino J, Mourtada F, Abdel-Wahab M, Jhingran A, Simonds H, Mahantshetty U (2023). The American Brachytherapy Society and Indian Brachytherapy Society consensus statement for the establishment of high-dose-rate brachytherapy programs for gynecological malignancies in low- and middle-income countries. Brachytherapy. 22(6):716-727. PMID: 37704540

  71. Gulia S, Kannan S, Ghosh J, Rath S, Maheshwari A, Gupta S (2023). Secondary cytoreduction in platinum sensitive relapsed ovarian cancer: An individual patient level meta-analysis. International Journal of Gynecological Cancer. 33(9):1440-1447. PMID: 37567595

  72. Gupta D, Singh A, Gupta N, Mehra N, Bahuguna P, Aggarwal V, Krishnamurthy MN, Roy PS, Malhotra P, Gupta S, Kumar L, Kataki A, Prinja S(2023). Cost-effectiveness of the first line treatment options for metastatic renal cell carcinoma in India. JCO Global Oncology. PMID: 36795991.

  73. Gupta SK, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kaushal RK, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Hasan SK, Sandur SK, Hingorani L, Khattry N, Gota V (2023). Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121: 110437. PMID: 37311352.

  74. Gupta T, Maheshwari G, Joshi K, Sawant P, Mishra A, Khairnar S, Patel P, Sinha S, Swain M, Budrukkar A, Ghosh-Laskar S, Agarwal JP (2023. Image-guidance triggered adaptive radiation therapy in head and neck squamous cell carcinoma: single-institution experience and implications for clinical practice. Journal of Medical Imaging and Radiation Sciences. 54(1):88-96. PMID: 36517346

  75. Gupta T, Selvarajan JMP, Kannan S, Menon N, Dasgupta A, Chatterjee A (2023). Updated systematic review and meta-analysis of extended adjuvant temozolomide in patients with newly diagnosed glioblastoma. Neuro-oncology Advances.13; 5(1):vdad086. PMID: 37638346

  76. Hande V, Chopra S, Polo A, Mittal P, Kohle S, Ghadi Y, Mulani A, Kinhikar R, Agarwal JP (2023). Transitioning India to advanced image based adaptive brachytherapy: A national impact analysis of upgrading National Cancer Grid cervix cancer guidelines. Lancet Regional Health- Southest Asia.16:100218. PMID: 37694176

  77. Handley KF, Mehta S, Martin AL, Biswas S, Maharaj K, Nagy MZ, Mine JA, Cortina C, Yu X, Sprenger K, Mandal G, Innamarato P, Powers JJ, Harro CM, Chaurio RA, Anadon CM, Shahzad MM, Flores I, Conejo-Garcia JR (2023) . Actionable spontaneous antibody responses antagonize malignant progression in ovarian carcinoma. Gynecologic Oncology. 173: 114-121. PMID: 37121178

  78. Harkenrider M, Fields E, Chopra S, Damast S, Kidd E, Chino J (2023). Recent key Studies in cancers of the uterine corpus and cervix: New updates in immunotherapy, the microbiome, bone density, quantifying lymphovascular invasion, and hypofractionated pelvic radiation therapy. International Journal of Radiation Oncology Biology Physics. 115(2): 269-275. PMID: 36621226

  79. Harro CM, Sprenger KB, Chaurio RA, Powers JJ, Innamarato P, Anadon CM, Zhang Y, Biswas S, Mandal G, Mine JA, Cortina C, Nagy MZ, Martin AL, Handley KF, Borjas GJ, Chen PL, Pinilla-Ibarz J, Sokol L, Yu X, Conejo-Garcia JR. Sézary Syndrome originates from heavily mutated hematopoietic progenitors. Blood Advances. 7(18): 5586-5602. PMID: 37531660

  80. Hegde MM, Sandbhor P, Aishwarya J, Gota V, Goda JS. Insight into lipid-based nanoplatform-mediated drug and gene delivery in neuro-oncology and their clinical prospects. Frontiers in Oncology. 13:1168454. PMID: 37483515

  81. Im SA, Gennari A, Park YH, Kim JH, Jiang ZF, Gupta S, Fadjari TH, Tamura K, Mastura MY, Abesamis-Tiambeng MLT, Lim EH, Lin CH, Sookprasert A, Parinyanitikul N, Tseng LM, Lee SC, Caguioa P, Singh M, Naito Y, Hukom RA, Smruti BK, Wang SS, Kim SB, Lee KH, Ahn HK, Peters S, Kim TW, Yoshino T, Pentheroudakis G, Curigliano G, Harbeck N (2023). Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer. ESMO Open. 8(3): 101541.PMID: 37178669

  82. Inchanalkar M, Srivatsa S, Ambatipudi S, Bhosale PG, Patil A, Schäffer AA, Beerenwinkel N, Mahimkar MB (2023). Genome-wide DNA methylation profiling of HPV-negative leukoplakia and gingivobuccal complex cancers. Clinical Epigenetics. 15(1): 93. PMID: 37245006

  83. Jadhav P, Pansare K, Hole A, Ingle A, Govekar R, CM Krisha (2023). Serum Raman Spectroscopy in experimental carcinogenesis hamster buccal pouch model: exploring early diagnostic capability. Journal of Raman Spectroscopy. 54(1): 37-46.

  84. Jain B, Christopher Dee E, Jain U, Chaturvedi P, Murthy V. (2023) The implications of rising alcohol-associated cancer burden: Considerations for the Indian context. Asia Pacific Journal of Clinical Oncology. 19(1):275-276 PMID: 35098671.

  85. Jha AK, Mthun S, Sherkhane U, Jaiswar V, Osong B, Purandare N, Kannan S, Prabhash K, Gupta S, Vanneste B, Rangarajan V, Dekker A, Wee L (2023). Systematic review and meta-analysis of prediction models used in cervical cancer.Artificial Intelligence in Medicine. 139:102549. PMID: 37100501

  86. Jindal N, C M, Mathew LJ, Kumbhalwar K, Patel K, Garg M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Khattry N (2023). Fertility outcomes in patients desiring conception following autologous stem cell transplantation for Hodgkin lymphoma using LACE conditioning. Bone Marrow Transplantation. PMID: 38102211

  87. Jindal N, Saroha M, Mirgh S, Chichra A, Nayak L, Bonda A, Gokarn A, Punatar S, Bagal B, Chavan P, Mathew LJ, Kanan S, Khattry N (2023). Relevance of vitamin D in patients undergoing HLA matched allogeneic stem cell transplant for acute leukemia. Transplant Immunology. 81:101925. PMID: 37648032.

  88. Joshi M, Dey P, De A (2023). Recent advancements in targeted protein knockdown technologies-emerging paradigms for targeted therapy. Exploration of Targeted Antitumor Therapy. 4(6):1227-1248. PMID: 38213543

  89. Joshi P, Bhattacharya K, Menon MB, Ghosh Laskar S, Joshi A, Patil V, Chaturvedi P. Malignant Minor Salivary gland neoplasms ofLarynx: Our Experience. Polish Journal of Otolaryngology. 77(5):1-7. PMID: 38032326.

  90. Joshi P, Waghmare S (2023). Molecular signaling in cancer stem cells of tongue squamous cell carcinoma: Therapeutic implications and challenges. World Journal of Stem Cells 15(5): 438-452. PMID: 37342225

  91. Joshi S, Anantharaman D, Muwonge R, Bhatla N, Panicker G, Butt J, Usha Rani Reddy Poli, Malvi S, Esmy P, Lucas E, Verma Y, Shah A, Zomawia E, Pimple S, Jayant K, Hingmire S, Chiwate A, Divate U, Vashist S, Mishra G, Jadhav R, Siddiqi M, Sankaran S, Thiraviam Pillai Rameshwari Ammal Kannan, Kartha P, Shastri S, Sauvaget C, M. Radhakrishna Pillai, Waterboer T, Müller M, Sehr P, Unger E, Sankaranarayanan R, Basu P (2023). Evaluation of immune response to single dose of quadrivalent HPV vaccine at 10-year post-vaccination. Vaccine. 41(1): 236-245. PMID: 36446654

  92. Joshi S, Ramarajan L, Ramarajan N, Lee SS, Deshpande O, Fernandes E, Engineer M, Srivastava G, Vanmali V, Kannan S, Hawaldar R, Nair N, Parmar V, Thakkar P, Chitkara G, Gupta S, Badwe R (2023). Effectiveness of a decision aid plus standard care in surgical management among patients with early breast cancer: A randomized clinical Trial. JAMA Network Open. 6(10):e2335941. PMID: 37782500

  93. Kandekar S, Punatar S, Khattry N Gokarn A, Jindal N, Mirgh S, Chichra A, Tembhare P, Rane P, Gawade J, Mathew L, Patil A, Chiplunkar S, Kode J.Low levels of CD26 on certain cellular subtypes of donor harvest is associated with better clinical outcomes post allogeneic stem cell transplantation through regulation of NF-κB pathway and pro-inflammatory cytokines.International Immunopharmacology. 125(Part A): 111054.PMID: 37890379

  94. Kapoor A, Noronha V, Patil V, Menon N, Joshi A, Kumar A, Singh AK, Mahajan A, Janu A, Kumar R, Pai T, Chougule A, Shetty O, Prabhash K (2023). Clinical Profile, Practice Pattern, and Outcomes with First-Line Therapy in ALK-Positive Lung Cancer: Real-World Data from Resource-Constrained Settings. JTO Clinical and Research Reports. 4(1):100443. PMID: 36654881

  95. Khan MA, Varma AK (2023). In silico and structure-based assessment to classify VUS identified in the α-helical domain of BRCA2.Journal of Biomolecular Structure and Dynamics. 41(19):9879-9889 PMID: 36404616.

  96. Khanna D, Budukh A, Sharma P, Shruti T, Vishwakarma R, Sharma AN, Bagal S, Vikraman SM, Vaza Y, Anand A, Chaturvedi P, Pradhan S (2023). Role of verbal autopsy in cancer registration: A mixed-methods study from the population-based cancer registry of Northern India. Tropical Medicine and International Health. 28(8):629-640. PMID: 37430444.

  97. Khurud P, Gupta A, Krishnatry R, Panigrahi G, Phurailatpam RD, Menon S, Pal M, Bakshi G, Prakash G, Murthy V (2023). Optimizing Target Volume for Adjuvant Radiation Therapy in Penile Cancer. Practical Radiation Oncology. 13(3):e270-e277.PMID: 36460183.

  98. Kode J, Maharana J, Dar A, Mukherjee S, Gadewal N, Sigalapalli D, Kumar S, Panda D, Ghosh S, Keshry S, Mamidi P, Chattopadhyay S, Pradhan T, Kailaje V, Inamdar S, Gujjarwar V (2023).6-Shogaol exhibits anti-viral and anti-inflammatory activity in COVID-19-associated inflammation by regulating NLRP3 inflammasomes. ACS Omega. 8(2):2618-2628. PMID: 36687062

  99. Koppikar S, Oakin A, Babu KG, Lorusso D, Gupta S, We L-Y, Rajabto W, Harano K, Hong S-H, Malik RA, Strebel H, Aggarwal IM, Lai C-H, Dejthevaporn T, Tangjitgamol S, Cheng WF, Chay WY, Benavides D, Hashim NM, Moon YW, Yunokawa M, Anggraeni TD, Wei W, Curigalina G, Maheshwari A, Mahantshetty U, Sheshadri S, Peters S, Yoshino T, Pentheroudakis G (2023). Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer. ESMO Open. 8(1): 10074. PMID: 36696825

  100. Krishnatry R, Maitre P, Kumar A, Telkhade T, Bakshi G, Prakash G, Pal M, Joshi A, Menon S, Murthy V (2023). Utilising alternative cystoscopic schedules to minimise cost and patient burden after trimodality therapy for muscle-invasive bladder cancer. Cancer Medicine. 12(10):11305-11314. PMID:36965102

  101. Kumar A, Jha AK, Agarwal JP, Yadav M, Badhe S, Sahay A, Epari S, Sahu A, Bhattacharya K, Chatterjee A, Ganeshan B, Rangarajan V, Moyiadi A, Gupta T, Goda JS (2023). Machine-Learning-Based Radiomics for Classifying Glioma Grade from Magnetic Resonance Images of the Brain. Journal of Personalized Medicine.13 (6):920. PMID: 37373909

  102. Kumar Gupta S, Gohil D, Dutta D, Panigrahi GC, Gupta P, Dalvi K, Khanka T, Yadav S, Kumar Kaushal R, Chichra A, Punatar S, Gokarn A, Mirgh S, Jindal N, Nayak L, Tembhare PR, Khizer Hasan S, Kumar Sandur S, Hingorani L, Khattry N, Gota V. Withaferin-A alleviates acute graft versus host disease without compromising graft versus leukemia effect. International Immunopharmacology. 121:110437. PMID: 37311352

  103. Kumar M, Moiyadi A, Rangaraj N, Noronha S, Shetty P, Singh VK, Choudhari AK (2023). Implications of use of different intraoperative ultrasound modalities during glioma surgery – a comparative study of factors affecting outcomes. International Journal of Medical Informatics.177:105154. PMID: 37506442

  104. Kumbhalwar K, Punatar S, Gokarn A, Nayak L, Chichra A, Mirgh S, Jindal N, Mathew L, Khattry N (2023). Lenalidomide with or without dexamethasone for relapsed or refractory Hodgkin lymphoma post autologous stem cell transplant. Blood Cell Therapy. 6(3):95-103. PMID: 38146353

  105. Kuru D, Kumar AK, Chaturvedi P (2023). Barriers in quest for cancer care access in two states of northeast India. The International Journal of Health Planning and Management. ;38(5):1396-1408. PMID: 37270797

  106. Lall S, Bhat V, Biswas S, Joshi A, Janu A (2023). Delftia acidovorans: An unusual pathogen from an adenocarcinoma lung patient with pleural effusion. Journal of Global Infectious Diseases. 15(3): 121-123. PMID: 37800087

  107. Laskar SG, Chaukar D, Deshpande M, Chatterjee A, Sinha S, Chakraborty S, Agarwal JP, Gupta T, Budrukkar A, Murthy V, Pai P, Chaturvedi P, Pantvaidya G, Deshmukh A, Nair D, Nair S, Prabhash K, Swain M, Kumar A, Noronha V, Patil V, Joshi A, DCruz A. Oral cavity adjuvant therapy (OCAT) -a phase III, randomized controlled trial of surgery followed by conventional RT (5 fr/wk) versus concurrent CT-RT versus accelerated RT (6fr/wk) in locally advanced, resectable, squamous cell carcinoma of oral cavity. European Journal of Cancer. 181:179-187. PMID: 36669426.

  108. Leung K, McLeod M, Torode J, Ilbawi A, Chakowa J, Bourbeau B, Sengar M, Booth CM, Gralow JR, Sullivan R, Aggarwal A(2023). Quality indicators for systemic anticancer therapy services: a systematic review of metrics used to compare quality across healthcare facilities. European Journal of Cancer. 195:113389. PMID: 37924649.

  109. Madhugiri V, Venkatesan S, Dutt A, Moiyadi AV, Shetty P, Gupta T, Epari S, Jalali R, Sasidharan GM, Kumar VR, Ganesh S, Ramesh A, Prabhu A, Dutt A (2023). An analysis of eosinophil and basophil based indices in patients with glioblastoma and their correlation with survival. World Neurosurgery. 170:e292-e300. PMID: 36368458

  110. Madkaiker D, Hiregoudar SS, Chavan P, Ojha S, Mendes J, Shastry S (2023). 'Ironing out the risk': Assessing the effect of plateletpheresis donation frequency on iron stores in South-Asian male donors. Vox Sanguinis. 18(11):921-929. PMID: 37772675

  111. Mahadik P, Patwardhan S (2023). ECM stiffness-regulated exosomal thrombospondin-1 promotes tunneling nanotubes-based cellular networking in breast cancer cells. Archives of Biochemistry and Biophysics.742:109624.PMID: 37146866

  112. Mahantshetty U, Kashid S, Mulye G, Gurram L, Engineer R, Chopra S, Ghosh J, Gulia S, Gupta S, Ghadi Y, Dheera A, Kohle S, Kadam S, Menon S, Deodhar K, Maheshwari A, Shylasree TS, Lewis S, Kalyani N, Shrivastava SK (2023). Reirradiation with advanced brachytherapy techniques in recurrent GYN cancers. Brachytherapy. 22(6):753-760. PMID: 37716821

  113. Mailankody S, Bajpai J, Budukh A, Swaminathan R, Dikshit R, Dhimal M, Perera S, Tshomo U, Bagal S, Bhise M, Chaturvedi P, Banavali S, Gupta S, Badwe R, Trama A. (2023) Epidemiology of rare cancers in India and South Asian countries-remembering the forgotten. Lancet Regional Health - Southeast Asia. 12:100168. PMID: 37384065

  114. Majumdar S, Sharma N, Sengar M, Thorat J, Nayak L, Bonda A, Bagal B, Rajendra A, Sethi A, Jain H (2023). A phase II study to evaluate the efficacy of low-dose rasburicase (1.5mg) in adolescent and adult acute leukemia and high-grade lymphomas with tumor lysis syndrome. Leukemia and Lymphom 64(3):628-638. PMID: 36891578

  115. Mani S, Chatterjee A, Dasgupta A, Shirsat N, Epari S, Chinnaswamy G, Gupta T (2023). WNT-pathway medulloblastoma: what constitutes low-risk and how low can one go? Oncotarget. 14: 105-110. PMID: 36749287.

  116. Mehta D, Shaikh S, Mohanty B, Chaudhari P, Waghmare SK (2023). Secretory phospholipase (sPLA2-IIA) regulates breast cancer stem cells differentiation and metastatic potential. Biochemical and Biophysical Research Communication. 677:98-104. PMID: 37566923.

  117. Mittal N, Patil A, Singhal P, Bal MM, Rane SU, Thiagarajan S(2023). Histoplasmosis of the Head and Neck Region Mimicking Malignancy: A Clinic-Pathological Predicament. Turkish Journal of Pathology 39(2):133-139. PMID: 35989588.

  118. Mittal P, Chopra S, Kamrava M, Vashistha R, Konrad S, Senapati S, Pradhan S, Reddy VA, Sharma DN, Engineer R, Sarin R, Budrukkar A, Ghoshal S, Shrivastava SK, Agarwal JP, Sturdza AE (2023). Brachytherapy training in India: Results from the GEC-ESTRO-India survey. Brachytherapy.22(4):562-569. PMID: 37193616.

  119. Mohanty P, Shetty D, Patkar N (2023). t(4;11) (p14;q23),KMT2A::PDS5A, in a case of pediatric B acute lymphoblastic leukemia (B-ALL). Atlas of Genetics and Cytogenetics in Oncology and Haematology.

  120. Mohanty SK, Wadasadawala T, Sen S, Khan PK (2023). Socio-economic variations of breast cancer treatment and discontinuation: a study from a public tertiary cancer hospital in Mumbai, India. BMC Womens Health. 23(1):113. PMID: 36935486

  121. Mohite A, Rangarajan V, Goda J, Chugh S, Agrawal A, Sengar M. (2023). Metabolic tumor parameters complement clinicopathological factors in prognosticating advanced stage Hodgkin Lymphoma. Asia Oceania Journal of Nuclear Medicine & Biology. 11(2):111-121 PMID: 37324230

  122. Moiyadi A, Jain K, Shetty P, Singh VK, Radhakrishnan K, Rane P, Velayutham P (2023). Baseline neurocognitive dysfunction is ubiquitous in intrinsic brain tumors– results from a large Indian cohort of patients and analysis of factors associated with domain-specific dysfunction. World Neurosurgery: X. 19:100210. PMID: 37251242

  123. Moiyadi A, Shetty P, Singh V, Yeole U (2023). Intraoperative navigated three dimensional-ultrasound guidance improves resection in gliomas as compared to standard two-dimensional ultrasound – Results from a comparative cohort study. World Neurosurgery. 180:e233-e242. PMID: 37739176

  124. Mujawar A, Phadte P, Palkina KA, Markina NM, Mohammad A, Thakur BL, Sarkisyan KS, Balakireva AV, Ray P, Yamplosky I, De A (2023). Triple reporter assay: A non-overlapping luciferase assay for the measurement of complex macromolecular regulation in cancer cells using a new mushroom luciferase-luciferin pair. Sensors (Basel). 23(17): 7313. PMID: 37687774

  125. Mundhe D, Mishra R, Basu S, Dalal S, Kumar S, Teni T (2023). ΔNp63 overexpression promotes oral cancer cell migration through hyperactivated Activin A signaling. Experimental Cell Research. 431(1):113739. PMID: 37567436

  126. Murthy V, Maitre P, Singh M, Pal M, Arora A, Pujari L, Kapoor A, Pandey H, Sharma R, Gudipudi D, Joshi A, Prabhash K, Noronha V, Menon S, Mehta P, Bakshi G, Prakash G (2023). Study protocol of the Bladder Adjuvant RadioTherapy (BART) trial: A randomised phase III trial of adjuvant radiotherapy following cystectomy in bladder Cancer. Clinical Oncology.35(9):e506-e515.PMID: 37208232

  127. Nag S, Dikshit R, Desai S, Mane A, Mhatre S, Neve R, Gurav M, Bhosale N, Perumal P, Kembhavi Y, Jethwa D, Badwe R, Gupta S (2023). Risk factors for the development of triple-negative breast cancer versus non-triple-negative breast cancer: a case-control study. Scientific Reports.13(1):13551. PMID: 37599285

  128. Nair N, Ali B, Siddique S, Maheshwari A, Bajpai J, Parmar V, Gulia S, Chitkara G, Joshi S, Hawaldar R, Badwe R. Patient-related awareness of impact of cancer-directed therapy on fertility in young women diagnosed of breast cancer. South Asian Journal of Cancer.

  129. Nair N, Das A, Shet T, Kirti K, Hawaldar R, Desai S, Parmar V, Joshi S, Badwe RA (2023). Accuracy of intraoperative frozen section analysis of lymph nodes in women undergoing axillary sampling for treatment of breast cancer: Single institution audit. Clinical Breast Cancer.23(7):e420-e423.PMID: 37460382

  130. Nair NS, Kothari B, Gupta S, Kanann S, Vanmali V, Hawaldar R, Tondare A, Siddique S, Parmar V, Joshi S, Badwe RA (2023). Validation of PREDICT Version 2.2 in a Retrospective Cohort of Indian Women with Operable Breast Cancer. JCO Global Oncology. PMID: 38085062.

  131. Nath A, Mathur P, Sudarshan KL, Kaur Rajput G, Mascarenhas L, Arora RS, Seth R, Kumar Dixit S, Chinnaswamy G, Banipal RPS, Bhutia TW, Kumar Bodal V, Budukh A, Kumar Chaudhary N, Vijay CR, Shikha Das D, Gundeti S, Harris C, Hazarika M, Natha Jondhale S, Gunaseelan K, Khamo V, Konjengbam R, Kumar A, Saroj Kumar DM, Majumdar G, Malik S, Mandal S, Najmi AM, Mohan Kumar C, Kumar Pandey A, Pandya S, Pareek P, Pautu JL, Surya Rao V, Ramesh C, Rawal M, Radhakrishnan N, Radhakrishnan V, Shah A, Singh SB, Singh V, Singh P, Sundriyal D, Swaminathan R, Avinash T, Priya Kumari T, Tawsik S, Tiwari L. An assessment of childhood cancer care services in India - gaps, challenges and the way forward. Lancet Regional Health - Southeast Asia.16:100235. PMID: 37694177

  132. Natu A, Pedgaonkar A, Gupta S (2023). Mitochondrial dysfunction and chromatin changes with autophagy-mediated survival in doxorubicin resistant cancer cell lines. Biochemical and Biophysical Research Communications. 648:1-10. PMID: 36724554

  133. Nautiyal A, Jha AK, Konuparamban A, Mithun S, Srichandan T, Puranik A, Gala K, Shetty N, Kulkarni S, Rangarajan V (2023). A dosimetric comparison of systemic peptide receptor radionuclide therapy and intra-arterial peptide receptor radionuclide therapy in patients with liver dominant gastroenteropancreatic neuroendocrine tumours. Nuclear Medicine Communications. 44(7):585-595. PMID: 37038926.

  134. Navarange SS, Bane SM, Mehta D, Shah S, Gupta S, Waghmare SK (2023). Epithelial-to-mesenchymal transition status correlated with ultrastructural features, and TP53 mutation in patient-derived oral cancer cell lines. Molecular Biology Reports. 50(10):8469-8481. PMID: 37639153

  135. Nehra P, Singh Chauhan A, Malhotra P, Kumar L, Singh A, Gupta N, Mehra N, Mathew A, Kataki AC, Gupta S, Prinja S (2023).Cost-effectiveness analysis of different combination therapies for the treatment of chronic lymphocytic leukaemia in India. The Lancet Regional Health - Southeast Asia. 13: 100201. PMID: 37383548

  136. Noronha V, Rao AR, Ramaswamy A, Kumar A, Pillai A, Dhekale R, Krishnamurthy J, Kapoor A, Gattani S, Sehgal A, Kumar S, Castelino R, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajan P, Timmanpyati S, Nookala M, Chitre A, Narasimhan PN, Banerjee J, Gota V, Banavali S, Badwe R, Prabhash K. (2023) The current status of geriatric oncology in India. Ecancer. 17:1595. PMID: 37799956

  137. Oak S, Karajgikar O, Teni T (2023). Curcumin mediates selective aggregation of mutant p53 in cancer cells a promising therapeutic strategy. Biochemical and Biophysical Research Communications. 677:141-148.PMID: 37586212

  138. Oike T, Kakoti S, Sakai M, Matsumura A, Ohno T, Shibata A. Analysis of the relationship between LET, γH2AX foci volume and cell killing effect of carbon ions using high-resolution imaging technology. Journal of Radiation Research. 64(2):335-344. PMID: 36621883

  139. Ostwal V, Ramaswamy A, Bhargava P, Srinivas S, Mandavkar S, Chaugule D, Peelay Z, Baheti A, Tandel H, Jadhav V, Shinde S, Jadhav S, Gota V, Mittra I (2023). A pro‑oxidant combination of resveratrol and copper reduces chemotherapy‑related non‑haematological toxicities in advanced gastric cancer: results of a prospective open label phase II single‑arm study (RESCU III study). Medical Oncology. 40:17.PMID: 36372825

  140. Pagdhune A, Kashyap R, SivaPerumal P, Balachandar R, Viramgami A, Sarkar K (2023). Occupational exposure of vehicular emissions and cardiorespiratory risk among urban metropolitan bus drivers: A cross-sectional comparative study. Work.75(4):1309-1318 PMID: 36744353

  141. Panda TR, Manikandan M, Vaidya SP, Chhatar S, Sinha S, Mehrotra M, Chakraborty S, Gadre S, Duari P, Ray P, Patra M (2023). The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity. Angewandte Chemie .62(38):e20230395. PMID: 37314332

  142. Parui AL, Bose K (2023). Purification of hetero-oligomeric protein variants using a modified tandem affinity purification approach. STAR Protocols. 4(1): 102036. PMID: 36853657

  143. Patil A, Diwakar H, Sawant J, Kurian N, Yadav S, Rane S, Bameta T, Sethi A (2023). Efficient quality control of whole slide pathology images with human-in-the-loop training. Journal of Pathology Informatics. PMID: 37089617

  144. Patil V, Noronha V, Menon N, Mathrudev V, Bhattacharjee A, Nawale K, Parekh D, Banavali S, Prabhash K (2023). Metronomic adjuvant chemotherapy evaluation in locally advanced head and neck cancers post radical chemoradiation–a randomised trial. Lancet Regional Health - Southeast Asia. 12:100162. PMID: 37384061

  145. Patil VM, Noronha V, Menon N, Rai R, Bhattacharjee A, Singh A, Nawale K, Jogdhankar S, Tambe R, Dhumal S, Sawant R, Alone M, Karla D, Peelay Z, Pathak S, Balaji A, Kumar S, Purandare N, Agarwal A, Puranik A, Mahajan A, Janu A, Kumar Singh G, Mittal N, Yadav S, Banavali S, Prabhash K(2023). Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study. Journal of Clinical Oncology. 41(2):222-232.PMID: 36265101

  146. Patnam N, Trivedi K, Janu A, Kaushal RK, Kulkarni S, Ankathi SK (2023). Cross-sectional imaging review of common to uncommon lung cancer mimickers in a tertiary care oncology center. Acta Radiologica. 64(10):2731-2747. PMID: 37592920

  147. Pattanaik S, Gota V, Tripathi SK, Kshirsagar NA (2023). Therapeutic drug monitoring in India: A SWOT analysis. British Journal of Clinical Pharmacology. 89(11):3247-3261. PMID: 37259249

  148. Paul S, Gupta T, Purandare N, Joshi K, Ghosh-Laskar S, Budrukkar A, Swain M, Sinha S, Kumar A, Joshi A, Prabhash K, Nair S, Rangarajan V, Agarwal JP (2023). Diagnostic performance of response assessment FDG-PET/CECT in HNSCC treated with definitive Radio (chemo)therapy using NI-RADS. Otolaryngology- Head and Neck Surgery. 169(4):938-947. PMID: 36856038

  149. Pelizzola M, Tanderup K, Chopra S, Jürgenliemk-Schulz IM, Nout R, Kirchheiner K, Spampinato S (2023). Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis. Acta Oncologica. 62(11):1479-1487. PMID: 37906286.

  150. Phurailatpam R, Sah MK, Wadasadawala T, Khan A, Palottukandy J, Gayake U, Jain J, Sarin R, Pathak R, Krishnamurthy R, Joshi K, Swamidas J (2023). Can knowledge based treatment planning of VMAT for post-mastectomy locoregional radiotherapy involving internal mammary chain and supraclavicular fossa improve performance efficiency? Frontiers in Oncology. 13:991952. PMID: 37114138

  151. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DQB1*06:01:01:04 allele in an individual from Western India. HLA. 101(1):90-91. PMID: 36086916.

  152. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-C*12:02:47 allele in an individual from Maharashtra, India. HLA. 101(1):74-75. PMID: 36161710

  153. Pinto AS, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DQA1*01:01:01:10 allele in an individual from Orissa, India. HLA. 101(2):190-191. PMID: 36181697

  154. Pinto AS, Tambe M, D'Silva SZ, Singh M(2023)Identification of the novel HLA-DQB1*06:01:01:04 allele in an individual from Western India. HLA. 101(1):90-91. PMID: 36086916

  155. Poon D, Yuan J, Yang B, Kerkmeijer L, Kishan A, Murthy V, Zapaetero A, Wong O (2023). Magnetic resonance imaging–guided focal boost to intraprostatic lesions using external beam radiotherapy for localized prostate cancer: A systematic review and meta-analysis. European Urology Oncology. 6 (2): 116-127.

  156. Pramesh CS, Sengar M, Patankar S, Chinnaswamy G, Gupta S, Vijayakumar M, Sood S, Sathe AN, Radhakrishnan V, Ganesan P, Mallavarapu KM, Badwe RA. A National Cancer Grid pooled procurement initiative, India. Bulletin of World Health Organization. 101(9):587-594. PMID: 37638358;

  157. Prinja S, Dixit J, Gupta N, Dhankhar A, Kataki AC, Roy PS, Mehra N, Kumar L, Singh A, Malhotra P, Goyal A, Rajsekar K, Krishnamurthy MN, Gupta S (2023). Financial toxicity of cancer treatment in India: towards closing the cancer care gap. Frontiers in Public Health. 11:1065737. PMID: 37404274

  158. Priyadharshn Selvarajan JM, Epari S, Sahu A, Dasgupta A, Chatterjee A, Gupta T (2023) . Pearls & Oy-sters: Primary diffuse leptomeningeal melanocytosis: A diagnostic conundrum. Neurology. PMID: 36878703

  159. Puja R, Dutta S, Bose K (2023). Elucidating the interaction of C-terminal domain of Vaccinia-Related Kinase 2A(VRK2A) with B-cell lymphoma-extra Large(Bcl-xL) to decipher its anti-apoptotic role in cancer. Biochemical Journal. 480(22):1871-1885. PMID: 37943248.

  160. Raj S, Kattepur A, Shylasree TS, Mishra G, Patil A, Pimple S, Noronha S, Pramesh CS (2023). Novel educational training of para medical professionals in cervical cancer screening. Gynecologic Oncology Reports. 48:101241. PMID: 37520786

  161. Rajak J, Tambe M, D'Silva SZ, Singh M (2023). Identification of the novel HLA-DPA1*02:82 allele in a Punjabi individual. HLA. 101(1):94-95. PMID: 36073256.

  162. Rajak J, Tambe M, D'Silva SZ, Singh M (2023). Identification of the HLA-B*15:665 and HLA-C*12:02:02:23 alleles in individuals from the South Asia. HLA. 102(5):625-626.. PMID: 37551036.

  163. Rajendra A, Sengar M, Bonda VNA, Jain H, Nayak L, Thorat J, Shet T, Epari S, Laskar S, Aggarwal A, Rangarajan V, Gujral S, Bagal B, Kakoti S, Salvi O (2023). Outcomes and prognostic factors of patients with Extranodal NK T cell lymphoma (ENKTL). Leukemia Lymphoma. PMID: 37602660

  164. Ramaswamy A, Bhargava P, Srinivas S, Kannan S, Bhandare M, Chaudhari V, Mantri A, Kapoor A, Das S, Booma N, Chaugule D, Shrikhande SV, Ostwal V (2023). Perioperative modified FLOT versus EOX in locally advanced resectable gastric and gastro-oesophageal junction adenocarcinoma: Results of a matched-pair analysis. Journal of Gastrointestinal Cancer. 54(3):820-828. PMID: 36242748

  165. Rauniyar S, Pansare K, Sharda A, Singh S, Saha P, CM Krishna, Gupta S (2023). Raman spectroscopy revealed cell passage-dependent distinct biochemical alterations in radiation-resistant breast cancer cells. ACS Omega. 8: 5522-5532. PMID: 36816694

  166. Raveendran V, R GR, P T A, Bhasi S, C P R, Kinhikar RA (2023). Moving towards process-based radiotherapy quality assurance using statistical process control. Physica Medica. 112:102651.PMID: 37562233.

  167. Ravichandran G, Harijan D, Ganapathy N, Prabusankar G, De A, Rengan K (2023). The multifaceted role of degradable cobalt nanoparticles: Dual-target starvation and intracellular acidification engendering LC3-associated whole-cell autophagy. ACS Materials Letters. 5, 10, 2726–2738.

  168. Rekhi B, Bal M, Dharavath B, Dutt A, Pai P (2023. A rare case of a low-grade inflammatory leiomyosarcoma/histiocyte-rich rhabdomyoblastic tumor in the neck of an adolescent male. Turkish Journal of Pathology.PMID: 35642345

  169. Rekhi B, Dave V, Butle A, Dutt A (2023). Utility of immunohistochemical expression of H3.3K36M and DOG1 in the diagnosis of chondroblastomas: An experience from a tertiary cancer referral center. Annals of Diagnostic Pathology. 66: 152174. PMID: 37356274

  170. Saha P, Sawant S, Deshmukh A, Hole A, CM Krishna (2023). Serum Raman spectroscopy: Prognostic applications in oral cancers. Head Neck. 45(5):1244-1254. PMID: 36919570.

  171. Sahu A, Patnam N, Goda JS, Epari S, Sahay A, Mathew R, Choudhari A, Desai S, Dasgupta A, Chatterjee A, Pratishad P,Shetty P, Moiyadi A, Gupta T (2023). Multiparametric magnetic resonance imaging correlates of isocitrate dehydrogenase mutation in WHO high-Grade astrocytomas. Journal of Personalized Medicine. 13(1): 72. PMID: 36675733

  172. Sali AP, Prakash G, Murthy V, Joshi A, Shah A, Desai SB, Menon S (2023). Updates in staging of penile cancer: The evolution, nuances, and issues. Human Pathology. 133:76-86. PMID: 35714835.

  173. Sandbhor P, Goda J, Mohanty B, Gera P, Yadav S, Chekuri G, Chaudhari P, Dutt S, Banerjee R (2023). Targeted nano-delivery of chemotherapy via intranasal route suppresses in vivo glioblastoma growth and prolongs survival in the intracranial mouse model. Drug Delivery and Translational Research. 13(2):608-626. PMID: 36245060.

  174. Sawant P, Perera S, Jayanthi KGN, Ziyad AIA, Saoba S, Ervik M, Mery L, Bray F, Dikshit R, Budukh A (2023). Application of Rupantaran software to Sri Lankan hospitals: an innovative tool developed to merge population-based cancer registry data into CanReg5. Ecancermedicalscience. 17:1553.PMID: 37377679

  175. Scheltes D, Mohanty S, Smits G, Steen-Banasik E, Murthy V, Hoskin P (2023). Improving quality of life with brachytherapy for urological malignancies. Clinical Oncology. 35(8):516-523. PMID: 36764876

  176. Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT, Nout R, Nesvacil N, de Leeuw A, Pötter R, Kirisits C; EMBRACE Collaborative Group (2023). Risk factors for local failure following chemoradiation and magnetic resonance image-guided brachytherapy in locally advanced cervical cancer: Results from the EMBRACE-I Study. Journal of Clinical Oncology. 41(10):1933-1942 PMID: 36599120

  177. Sengar M, Jain H, Shet T, Sridhar E, Gota V, Rangarajan V, Laskar SS, Alahari A, Thorat J, Agarwal A, Sharma N, Gupta H, Kannan S, Kumar S, Nayak L, Menon H, Gujral S, Bagal B (2023). Phase II trial of a novel chemotherapy regimen CVEP (cyclophosphamide, vinblastine, etoposide and prednisolone) for acquired immunodeficiency syndrome (AIDS)-associated lymphomas. British Journal of Haematology. 200(4):429-439. PMID: 36323643.

  178. Setia P, Bargir UA, Shanmukhaiah C, Jodhawat N, Gaikwad P, Vedpathak D, Dutta S, Kulkarni R, Kambli P, Dalvi A, Shinde S, Gupta M, Nambiar N, Sawant S, Shelar S, Dhawale A, Mohanty M, Yadav RM, Bose K, Madkaikar M (2023). Expanding the clinical phenotype of FADD deficiency with a novel mutation and its role in Fas-mediated apoptotic pathway. British Journal of Haematology. 202(2):e11-e15. PMID: 37199216

  179. Shabrish S, Chandrakasan S, Madkaikar M (2023). NK cell defects: diagnosis and treatment. Frontiers in Immunology. 14:1323793. PMID: 38022628

  180. Shabrish S, Pal K, Khare N, Satsangi D, Pilankar A, Jadhav V, Shinde S, Raphael N, Sriram G, Lopes R, Raghuram G, Tandel H, Mittra I (2023). Cell-free chromatin particles released from dying cancer cells activate immune checkpoints in human lymphocytes: Implications for cancer therapy. Frontiers in Immunology.

  181. Shaikh MR, Singh B, Halder R, Singh R, Shaikh MR, Agarwal N, Bansal N, Ahmed R, Mirgh SP, Bhurani D (2023). FLAG based v/s Standard 3 + 7 induction therapy in treatment naïve Acute Myeloid Leukemia: Time to think "beyond anthracyclines". Leukemia Research. 132:107346. PMID: 37467566

  182. Shaikh ZM, Bhatia N, Aradhye P, Anbarasu A, Gawde J, Thorat R, Mahimkar MB (2023). Thearubigins/Polymeric black tea polyphenols (PBPs) do not prevent benzo[a]pyrene (B[a]P) induced lung tumors in A/J mice. American Journal of Translational Research. 15(9):5826-5834.PMID: 37854224

  183. Sharma D, Pawar SN, Sulkshane P, Waghole R, Yasser M, Pawar SS, Kannan S, Chaudhary N, Kalwar A, Patil R, Nair S, Dalal SN, Teni T (2023). Elevated translationally controlled tumour protein promotes oral cancer progression and poor outcome. Journal of Oral Pathology and Medicine. 52(9):849-859. PMID: 37573872.

  184. Shenoy R, Rao AR, Rane P, Noronha V, Kumar A, Pillai A, Pathak S, Gattani S, Sehgal A, Kumar S, Castelino R, Dhekale R, Krishnamurthy J, Mahajan S, Daptardar A, Sonkusare L, Deodhar J, Ansari N, Vagal M, Mahajam P, Timmanpyati S, Nokala M, Chitra A, Kapoor A, Gota V, Banavali S, Prabhash K, Ramaswamy A. Validation of the Onco-MPI in predicting short-term mortality in older Indian patients with cancer. Journal of Geratric Oncology. 14(6): 101550. PMID: 37327761

  185. Shrivastav G, Datta D, Wadasadawala T, Rane P, Panda S, Pathak R, Scaria L, Krishnamurthy R, Sarin R. (2023). Clinical audit of breast cancer patients treated with helical tomotherapy for irradiation of the internal mammary chain. Journal of Radiotherapy in Practice.22:E23.

  186. Shruti T, Khanna D, Khan A, Dandpat A, Tiwari M, Singh AG, Mishra A, Shetty A, Birur P, Chaturvedi P (2023). Status and determinants of early detection of oral premalignant and malignant lesions in India. Cancer Control.PMID: 36809192

  187. Singh A, Shetty D, Patil J, More M, Chatterjee G, Rajpal S, Patkar NV, Subramanian PG, Gujral S, Tembhare PR (2023). Acute basophilic leukemia in a patient with down syndrome: A case report and review of literature. International Journal of Laboratory Hematology. 45(6):972-978. PMID: 37334558

  188. Singh B, Patnaik C, Bahadur R, Gandhi M, De A, Srivastava R (2023). Synthesis and degradation mechanism of renally excretable gold core-shell nanoparticles for combined photothermal and photodynamic therapy. Nanoscale. 15(3):1273-1288. PMID: 36541678.

  189. Singh C, Karunakaran P, Yanamandra U, Jindal N, Kumar S, Saini N, Jandial A, Jain A, Lad D, Prakash G, Khadwal A, Kumar N, Naseem S, Ahluwalia J, Varma N, Varma S, Malhotra P (2023). Factors associated with thrombo-hemorrhagic deaths in patients with Acute Promyelocytic Leukemia treated with Arsenic Trioxide and All-Trans Retinoic Acid. Leukemia Research. 134:107392. PMID: 37774447

  190. Singh C, Yanamandra U, Karunakaran P, Jindal N, Kumar SR, Saini N, Jandial A, Jain A, Das C, Lad D, Prakash G, Khadwal A, Naseem S, Das R, Varma N, Varma S, Malhotra P (2023). Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy-a retrospective, single-centre study. British Journal of Haematology. 201(2):249-255. PMID: 36529704.

  191. Sinha S, Pandey S, Salins S, Salins N, Deodhar J, Gupta T, Laskar S, Budrukkar A, Swain M, Kumar A, Murthy V, Nair S, Nair D, Joshi P, Chaturvedi P, Menon N, Patil V, Joshi A, Noronha V, Prabhash K, Agarwal J(2023). Psycho-oncology/supportive care in head–neck cancers patients undergoing radiation therapy: A randomized controlled trial. South Asian Journal of Cancer.

  192. Soerjomataram I, Cabasag C, Bardot A, Fidler-Benaoudia M, Miranda-Filho A, Ferlay J, Parkin D, Ranganathan R, Piñeros M, Znaor A, Mery L, Joko-Fru Y, Dikshit R, Sankaranarayanan R, Swaminathan R, Bray F (2023).Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries. Lancet Oncology. 24 (1): 22-32. PMID: 36603919

  193. Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, C H W Lutgens L, Hoskin P, Smet S, Pötter R, Nout R, Chopra S, Kirchheiner K EMBRACE Collaborative Group (2023) Appendix. Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors. Radiotheray and Oncology. 181:109501. PMID: 36720348.

  194. Spohn S, Draulans C, Kishan A, Spratt D, Ross A, Maurer T, Tilki D, Berlin A, Blanchard P, Collins S, Bronsert P, Chen R, Pra A, Meerleer G, Eade T, Haustermans K, Hölscher T, Höcht S, Ghadjar P, Davicioni E, Heck M, Kerkmeijer L, Kirste S, Tselis N, Tran P, Pinkawa M, Pommier P, Deltas C, Schmidt-Hegemann N, Wiegel T, Zilli T, Tree A, Qiu X, Murthy V, Epstein J, Graztke C, Gao X, Grosu A, Kamran S, Zamboglou C (2023). Genomic classifiers in personalized prostate cancer radiotherapy approaches – A systematic review and future perspectives based on international consensus. International Journal of Radiation Oncology, Biology Physics. 116(3):503-520.PMID: 36596346

  195. Srinivasan S, Prasad M, Parambil BC, Shrimal A, Gollamudi VRM, Subramani V, Ramadwar M, Khanna N, Baheti AD, Gala K, Patil V, Laskar S, Qureshi S, Chinnaswamy G (2023). Treatment outcomes and prognostic factors in children with hepatoblastoma using a risk-stratified approach. Pediatric Blood Cancer. 70(7):e30302 .PMID: 37046413.

  196. Srinivasan S, Ramanathan S, Kumar S, Peyam S, Radhakrishnan V (2023). Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis. Annals of Hematology. 102(8): 2165-2179. PMID: 37154889

  197. Syamprasad NP, Rajdev B, Jain S, Panda S, Rao Puppala E, Chaudhari P, Rao Vaidya J, Kumar GJ, Naidu VGM (2023). Pivotal role of AKR1B1 in pathogenesis of colitis associated colorectal carcinogenesis. International Immunopharmacology.119: 110145. PMID: 37044030

  198. Tambe M, D'Silva SZ, Parsaniya B, Pinto AS, Singh M (2023) Identification of HLA-C*03:599 novel allele variant in two South Indian individuals in a Brahmin family. HLA. 101(1):66-67. PMID: 36088573.

  199. Tambe M, D'silva SZ, Pinto AS, Parsaniya B, Singh M (2023). Identification of the novel allele, HLA-A*02:11:01:06, in two North Indian individuals in a Kshatriya family. HLA. 101(1): 43-44. PMID: 36087311

  200. Tambe M, D'Silva SZ, Pinto AS, Singh M (2023). Characterization of the novel HLA-B*58:01:01:19 allele by next-generation sequencing. HLA. 101(2):173-174. PMID: 36239076

  201. Thomas M, Agarwal V, DeSouza A, Joshi R, Mali M, Panhale K, Salvi OK, Ambulkar R, Shrikhande S, Saklani A(2023). Enhanced recovery pathway in open and minimally invasive colorectal cancer surgery: a prospective study on feasibility, compliance, and outcomes in a high-volume resource limited tertiary cancer center. Langenbeck's Archives of Surgery 408(1):99. PMID: 36811742

  202. Tiwari M, Pandey A, Rautham A, Chavan P, Bhat V (2023). Implementation of a quality management system in accordance with ISO15189 - Evaluation of accredited versus non-accredited resource limited medical laboratories in several Indian states. European Chemical Bulletin. 12 (S3):3867 – 3873.

  203. Tongaonkar A, Simha V, Menon N, Noronha V, Bakshi G, Murthy V, Menon S, Sable N, Krishnantry R, Popat P, Palak P, Prakash G, Agarwal A, Jadhav B, Prabhash K, Joshi A. Management of testicular tumours in patients with undescended testes— a challenging but rewarding task: experience from a tertiary care cancer centre in India. ecancermedicalscience.17: 1521. PMID: 37113713

  204. Trivedi B, Chawathey SA, Pinjari AN, Kataria KK. Intraoperative diagnosis of bilateral upper limb arteriovenous fistulae in a child: A case report. A &A Practice. 17(12):e01738. PMID: 38099715.

  205. Trivedi V, Noronha V, Sreekanthreddy P, Desai S, Poojary D, Varghese L, Gowda P, Butle A, Mishra R, Bal M, Mittal N, Rane S, Kane S, Basu S, Patil V, Menon N, Singh AK, Chaturvedi P, Chandrani P, Choughule A, Veldore V, Prabhash K, Dutt A. Association of Cutibacterium acnes with human thyroid cancer. Frontiers in Endocrinology (Lausanne). 14:1152514. PMID: 38027096

  206. Uthale A, Anatram A, Sulkshane P, Degani M, Teni T (2023). Identification of bicyclic compounds that act as dual inhibitors of Bcl-2 and Mcl-1. Molecular Diversity. 27:1359–1374 (2023) PMID: 35909144

  207. Vahabi M, Shahil-Feroz A, Lofters A, Wong JP, Prakash V, Pimple S, Anand K, Mishra G (2023). Surviving the Storm: The Impact of COVID-19 on Cervical Cancer Screening in Low- and Middle-Income Countries. Healthcare. 11(23):3079. PMID: 38063647

  208. Vengurlekar V, Shetty O, Gurav M, Bapat P, Karnik N, Wagh G, Epari S, Rekhi B, Ramadwar M, Desai S. BRAF V600E Mutations and Beyond: A Molecular Perspective of Melanoma from a Tertiary Cancer Referral Center of India. South Asian Journal of Cancer. 12(4):359-370. 1760759. PMID: 38130275

  209. Venkatesulu B, Liauw SL, Joshi M, Brian Baumann B, Yoo R, Roupret M, Choudhury A, Efstathiou J, Murthy V, Sargos P, Solanki A (2023). Multidisciplinary management and radiotherapy recommendations for clinically and pathologically node-positive bladder cancer. Seminars in Radiation Oncology. 33 (1): 35-50. PMID: 36517192

  210. Verghese G, Lennerz JK, Ruta D, Ng W, Thavaraj S, Siziopikou KP, Naidoo T, Rane S, Salgado R, Pinder SE, Grigoriadis A (2023). Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospects. Journal of Pathology. 260(5):551-563. PMID: 37580849

  211. Verghese G, Li M, Liu F, Lohan A, Kurian NC, Meena S, Gazinska P, Shah A, Oozeer A, Chan T, Opdam M, Linn S, Gillett C, Alberts E, Hardiman T, Jones S, Thavaraj S, Jones JL, Salgado R, Pinder SE, Rane S, Sethi A, Grigoriadis A (2023). Multiscale deep learning framework captures systemic immune features in lymph nodes predictive of triple negative breast cancer outcome in large-scale studies. Journal of Pathology. 260(4):376-389. PMID: 37230111

  212. Verma T, Natu A, Khade B, Gera P, Gupta S. An increase in polyadenylation of histone isoforms, Hist1h2ah and Hist2h3c2, is governed by 3'-UTR in de-differentiated and undifferentiated hepatocyte. Experimental Biology and Medicine (Maywood). PMID: 37021545.

  213. Vesprini D, Pathmanathan A, Murthy V. Elective nodal irradiation: Old game, new sport. International Journal of Radiation Oncology, Biology, Physics. 17(3): 610-612.PMID: 37739608

  214. Wadasadawala T, Datta D, Puchali N, Rane P, Sen S, Mohanty S, Gupta S, Sarin R, Parmar V (2023). Prospective Study of Incidence and Impact of Comorbidities on Breast Cancer Survival from India. Asian Pacific Journal of Cancer Prevention. 24(11):3805-3814. PMID: 38019238

  215. Wadasadawala T, Mohanty SK, Sen S, Khan PK, Pimple S, Mane JV, Sarin R, Gupta S, Parmar V (2023). Health-Related Quality of Life (HRQoL) Using EQ-5D-5L: Value set derived for Indian breast cancer ccohort. Asian Pacific Journal Cancer Prevention. 24(4):1199-1207. PMID: 37116141

  216. Wadasadawala T, Patil R, Carlton J, Verma S, Umesh N, Rane P, Sarin R, Pathak R, Bajpai J, Nair N, Shet T, Kaur R (2023). Long-term outcomes and prognostic factors in elderly patients with breast cancer: single-institutional experience. Ecancermedicalscience. 17:1542. PMID: 37377682

  217. Wilson BE, Booth CM, Suvillian R, Aggarwal A, Sengar M, Jacob S, Bray F, Barton MB, Pearson S-A (2023). Global application of National Comprehensive Cancer Network resource-stratified guidelines for systemic treatment of colon cancer: a population-based, customisable model for cost, demand, and procurement. Lancet Oncology. 24(6): 682-690. PMID: 37269845

  218. Yadav S, Mittal N, Rane SU, Bal M, Patil A, Ankathi SK, Nair D. Nonsalivary Primary Adenocarcinomas of the Base of Tongue. Archives of Pathology & Laboratory Medicine. 147(11):1278-128 2023 PMID: 36602895.

  219. Zhong AY, Lui AJ, Katz MS, Berlin A, Kamran SC, Kishan AU, Murthy V, Nagar H, Seible D, Stish BJ, Tree AC, Seibert TM (2023). Use of focal radiotherapy boost for prostate cancer: radiation oncologists' perspectives and perceived barriers to implementation. Radiation Oncology. 18(1):188. PMID: 37950310.
Category
International
Select Year
2023
order
0
Back to Top